Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
about
Molecular insights into proton coupled peptide transport in the PTR family of oligopeptide transportersCrystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2Structural insights into substrate recognition in proton-dependent oligopeptide transportersAlternating access mechanism in the POT family of oligopeptide transportersThe Concise Guide to PHARMACOLOGY 2013/14: transporters.Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson SyndromeEvidence of D-phenylglycine as delivering tool for improving L-dopa absorptionTransport of the areca nut alkaloid arecaidine by the human proton-coupled amino acid transporter 1 (hPAT1).Peptide transporter DtpA has two alternate conformations, one of which is promoted by inhibitor binding.Gold(III)-dithiocarbamato peptidomimetics in the forefront of the targeted anticancer therapy: preclinical studies against human breast neoplasia.Overexpression of membrane proteins from higher eukaryotes in yeasts.Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions.USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2.Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies.Structure determination of a major facilitator peptide transporter: Inward facing PepTSt from Streptococcus thermophilus crystallized in space group P3121.Hijacking solute carriers for proton-coupled drug transport.Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery.Pharmacogenetics of drug transporters in the enterohepatic circulation.Teleost fish models in membrane transport research: the PEPT1(SLC15A1) H+-oligopeptide transporter as a case study.Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.Extrahepatic metabolism at the body's internal-external interfaces.Tenapanor administration and the activity of the H+ -coupled transporter PepT1 in healthy volunteers.Preclinical activity of multiple-target gold(III)-dithiocarbamato peptidomimetics in prostate cancer cells and xenografts.Di- and tripeptide transport in vertebrates: the contribution of teleost fish models.A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1)The Ubiquitin ligase Ubr11 is essential for oligopeptide utilization in the fission yeast Schizosaccharomyces pombe.Gating topology of the proton-coupled oligopeptide symporters.The bioactive dipeptide anserine is transported by human proton-coupled peptide transporters.Effect of Janus kinase 3 on the peptide transporters PEPT1 and PEPT2.Expression and regulation of proton-coupled oligopeptide transporters in colonic tissue and immune cells of mice.Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: A microdialysis study.Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors.In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.Methionyl-Methionine Promotes α-s1 Casein Synthesis in Bovine Mammary Gland Explants by Enhancing Intracellular Substrate Availability and Activating JAK2-STAT5 and mTOR-Mediated Signaling Pathways.Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future
P2860
Q26830326-417A0177-8EC9-4CA4-BE6E-9775E8FB1CE8Q27666182-4640D373-8C39-4612-AF7A-ADB118725FFFQ27679133-792274D9-A7A9-4962-8391-C573FA60CF7BQ27679456-3424D22F-5603-4C18-AF8F-C4E2BC6F68CBQ30486743-4E860B14-F162-4ADD-8394-7AF31F7ED02CQ30932631-64178B53-C179-48A4-A961-10E15E38306FQ34137524-05B68C17-A7CF-4E45-A882-5F1B3C51DB42Q34332903-FD20EF19-7BDA-4BBD-96FE-676E28A4350BQ35003135-D3E2E921-B2FA-45D8-90FA-ED66DE926076Q35083349-8839500F-2FDF-41A6-AED2-DCB739560359Q35214601-F3973DAA-7E4B-42A7-A099-6770AF298239Q35575176-9B420902-4DD0-4D16-AC4A-8E6A8449882BQ35654199-0851DE3F-49FB-4BD3-BDC1-D811325EA865Q36105344-DD729380-B859-412E-8F5D-B20016FB8D78Q36298338-20C1F8D0-35CA-46A1-A696-FEF7FD904CACQ37824123-78497F5D-778D-43EB-BB7C-42FEA3F90BD9Q37824864-9F1DFA4B-D01E-47C7-8E63-3BA5C092A3BFQ37880875-A30967A2-961C-4053-ACA1-DA138BAE419EQ38131959-639D3A1C-62BD-4A05-BE0E-727E28B6A60BQ38183877-9CE4234B-70A0-41A3-B6EB-57C152BD7029Q38199198-06364C9C-4DC3-4B29-A90A-CBE858D80FF5Q38692100-6835BA84-3A3E-49F0-B0FD-D64883154408Q38962397-C9A01C53-50CE-4FE2-8C3C-437CF0BC38DFQ38996373-6D618B0E-ACF7-45A3-8E5A-649417F39D10Q39706601-66E73089-37FD-4D11-B36B-2DD05A9CE182Q42600987-0F7482F3-CDBC-4404-A9C3-DD398047FE3CQ43139307-289F9B2F-D9A4-4220-AA32-2428D514AB99Q43196429-3D5606F6-E7E9-40E7-BA85-73C7DB70BD8AQ44028421-B750C6BC-0479-43C8-9AA4-9AC67B7FD2FEQ47228223-0489D7CC-0DB0-4E28-B92E-581F22B44C83Q48311838-B289ADA3-6DE0-4C0C-8CFF-793F4FF79D99Q48588159-38E6FA6F-928E-40F5-B012-4502EEC8EE92Q50512905-D8466380-9B13-4687-9983-9F1B48AC6C53Q54263463-7CFF3DFF-0FC3-447F-B435-780B4C627935Q57158690-6AC52C79-52F1-41A6-A0FE-D1C0706F0188
P2860
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@en
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@nl
type
label
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@en
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@nl
prefLabel
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@en
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@nl
P2860
P1476
Transport of drugs by proton-coupled peptide transporters: pearls and pitfalls.
@en
P2093
Matthias Brandsch
P2860
P304
P356
10.1517/17425250903042292
P407
P577
2009-08-01T00:00:00Z